SAN FRANCISCO (Reuters) - A draft U.S. bill is circulating in Washington D.C. that would curb the U.S. Food and Drug Administration's regulatory oversight over electronic medical records and some clinical
Sign in to post comments.
Comments (0)
Sign in to post comments.